RxDoctor Payments Data

Hardie Sorrels, MD

Internal Medicine · Lebanon, TNNPI 1942314075

Payments from drug & device makers

$572in general payments, 2019–2025

Across 28 payments — averaging $20.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$252
  • GSK$82
  • Amgen$40
  • Inspire Medical Systems, Inc.$38
  • Cequr Corporation$31
  • Insulet Corporation$24
  • plus $105 from 6 others

What the payments were for

  • Food & beverage$572100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$572 in reported general payments places this provider in the 60th percentile of 2,216 internal medicine providers in Tennessee.

See all internal medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$226,438
Medicare patients
491
Services billed
6,000

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban62$78,803
JardianceEmpagliflozin98$64,223
XareltoRivaroxaban57$61,180
TrulicityDulaglutide54$61,147
MounjaroTirzepatide55$54,590
OzempicSemaglutide40$35,993
JanuviaSitagliptin Phosphate27$18,398
EntrestoSacubitril/Valsartan11$16,620
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog23$14,574
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$14,100
Tresiba Flextouch U-100Insulin Degludec20$13,115
JanumetSitagliptin Phos/Metformin Hcl22$12,077
Soliqua 100-33Insulin Glargine/Lixisenatide14$9,733
FarxigaDapagliflozin Propanediol14$8,910
Tresiba Flextouch U-200Insulin Degludec14$8,547

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta$82$20,23331 claims
AstraZenecaFarxiga$24$8,91014 claims
AbbVieSynthroid$252$6,917103 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$17$6,139622 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,216 internal medicine providers in Tennessee.

Other internal medicine in Lebanon

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →